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 The correlation of non-random karyotypic aberrations 
with the clinical behavior of human neoplasms is widely 
recognized as an approach for developing novel means for 
diagnosis, prognosis and therapeutic design. The expand-
ing field of cancer cytogenetics has stimulated the develop-
ment of a spectrum of techniques and resources with which 
such genomic changes can be detected and characterized 
(for example Cowell et al., 2004; Ishkanian et al., 2004). De-
spite this, the ability to translate the multitude of reported 
tumor-associated structural and numerical chromosome 
abnormalities into meaningful advances in clinical man-
 Abstract.  Molecular cytogenetic studies have been in-
strumental in defining the nature of numerical and struc-
tural chromosome changes in human cancers, but their sig-
nificance remains to be fully understood. The emergence of 
high quality genome assemblies for several model organ-
isms provides exciting opportunities to develop novel ge-
nome-integrated molecular cytogenetic resources that now 
permit a comparative approach to evaluating the relevance 
of tumor-associated chromosome aberrations, both within 
and between species. We have used the dog genome se-
quence assembly to identify a framework panel of 2,097 bac-
terial artificial chromosome (BAC) clones, selected at inter-
vals of approximately one megabase. Each clone has been 
evaluated by multicolor fluorescence in situ hybridization 
(FISH) to confirm its unique cytogenetic location in con-
cordance with its reported position in the genome assembly, 
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providing new information on the organization of the dog 
genome. This panel of BAC clones also represents a power-
ful cytogenetic resource with numerous potential applica-
tions. We have used the clone set to develop a genome-wide 
microarray for comparative genomic hybridization (aCGH) 
analysis, and demonstrate its application in detection of tu-
mor-associated DNA copy number aberrations (CNAs) in-
cluding single copy deletions and amplifications, regional 
aneuploidy and whole chromosome aneuploidy. We also 
show how individual clones selected from the BAC panel 
can be used as FISH probes in direct evaluation of tumor 
karyotypes, to verify and explore CNAs detected using 
aCGH analysis. This cytogenetically validated, genome in-
tegrated BAC clone panel has enormous potential for aiding 
gene discovery through a comparative approach to molecu-
lar oncology.  Copyright © 2008 S. Karger AG, Basel 
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agement has yet to reach its full potential. In part this stems 
from the challenge of establishing which aberrations are bi-
ologically significant versus those that are consequences of 
the disregulation of cell proliferation inherent to tumori-
genesis. Since many human cancers have direct counter-
parts in other species, a comparative approach to molecular 
oncology presents a means by which to address this chal-
lenge. Detection of evolutionarily-conserved tumor-associ-
ated chromosome aberrations in different species adds 
weight to their association with the disease process, whilst 
the comparative study of the specific sequences involved in 
recurrent genomic aberrations may clarify how chromo-
some structure and organization influences the transition 
from a normal to a malignant karyotype. 
 The immense value of the domestic dog as a model sys-
tem for human clinical research is particularly well recog-
nized, a consequence of the similarity in their physiology, 
their shared environment and the multitude of common 
and spontaneously-occurring conditions with an overtly 
genetic basis. Most importantly, the genomic homogeneity 
of many purebred domestic dog populations provides tre-
mendous opportunities to unearth the underlying etiology 
of shared genetic traits that have thus far been obscured in 
human studies by the vast heterogeneity of human popula-
tions. We have previously identified evolutionarily-con-
served chromosome aberrations in a range of dog cancers 
that may suggest an ancestrally retained pathogenetic 
mechanism of cancer (Dunn et al., 2000; Thomas et al., 
2003c, 2005; Breen and Modiano, 2008). More importantly, 
however, these studies have also revealed genomic changes 
in the canine counterpart that are thus far unreported in the 
human literature, perhaps as a result of the confounding ef-
fects of ‘noise’ in the human genome. In order to understand 
the biological and comparative relevance of these genomic 
changes it is essential to be able to interpret cytogenetic ob-
servations in direct context with their relevance to gene in-
volvement, both within and between species. The ability to 
perform fully informative translational studies of canine 
cancer cytogenetics has, however, been hindered by the use 
of dog genomics resources that have, by necessity, been reli-
ant primarily on anonymous genetic markers (Mellersh et 
al., 2000; Guyon et al., 2003; Thomas et al., 2003b, 2005; 
Breen et al., 2004). 
 The release of a high-quality, annotated 7.6 ! genome 
sequence assembly for the domestic dog (Lindblad-Toh et 
al., 2005) provides tremendous new opportunities to devel-
op and apply more sophisticated resources and techniques 
for comparative studies. We are able, for the first time, to 
compare the DNA sequence of any given chromosome re-
gion with the annotated dog genome assembly to establish 
precisely its gene content, and in turn to correlate it direct-
ly with the orthologous sequence in the genome assemblies 
of human, mouse and an increasing number of other spe-
cies. By localizing that DNA sequence to a defined cytoge-
netic location, we can establish with ease and accuracy how 
structural and numerical chromosome abnormalities affect 
the status of key genes. The utilization of the genome se-
quence assembly in context with the cytogenetic map of the 
dog therefore represents a powerful combination for inves-
tigating the range, frequency and implications of both struc-
tural and numerical chromosome abnormalities. Previous-
ly  we  developed  a  low-resolution  panel  of BAC clone 
 markers distributed at 10 Mb intervals along each dog chro-
mosome, as a means to aid chromosome identification and 
to permit rapid, first-pass analysis of genomic aberrations 
in dog tumors, prior to more detailed evaluation (Thomas 
et al., 2007). As a means to fully integrate the dog cytoge-
netic map with the genome sequence assembly, we have now 
developed a framework panel of 2097 cytogenetically vali-
dated bacterial artificial chromosome (BAC) clones selected 
at intervals of approximately one megabase (1 Mb) from the 
  2.4 Gb of euchromatic sequence in the dog genome assem-
bly. We demonstrate the excellent correlation between the 
cytogenetic map and the genome assembly, and discuss the 
wide range of potential applications of this BAC panel in 
canine and comparative genomics analysis. Finally, we pre-
sent the development of this BAC clone set into a 1 Mb res-
olution, genome-anchored microarray for comparative ge-
nomic hybridization (aCGH) analysis. We demonstrate how 
this tool enables direct translation of dog tumor-associated 
chromosome copy number changes into DNA sequence, re-
vealing the consequences of genomic aneuploidy on gene 
dosage, and providing exciting new opportunities for de-
tailed comparative cancer studies.
 Materials and methods  
 Identification of a 1 Mb resolution BAC panel from the dog 
genome assembly 
 Unless otherwise stated, all clones described in the present study 
were derived from the CHORI-82 dog BAC library (http://bacpac.ch-
ori.org, BACPAC Resources, Children’s Hospital Oakland Research In-
stitute, Oakland, CA), derived from a female Boxer, and from which 
the 7.6 ! dog genome assembly was constructed (Lindblad-Toh et al., 
2005). BAC paired-end read placements were used to identify clones 
distributed evenly along each of the 39 different chromosomes in the 
female dog, by reference to the genome assembly (version 2.0, May 
2005, Lindblad-Toh et al., 2005). For clones with ambiguous assembly 
placements the paired-end reads were aligned to the genome using 
BLAST. Only clones with high quality positioning of both ends in the 
genome, and with accurate relative positioning (50–400 kb apart), were 
candidates for inclusion in the map.
 Due to the presence of highly repetitive sequences at the centromere 
that are intractable to genome sequence assembly, the most proximal 
clone available on each of the dog autosomes was typically located ap-
proximately 3 Mb distal to the centromere (mean 3.17 Mb, range 3.01–
3.33 Mb). From this point, BAC clones were selected from the assembly 
at approximately 1 Mb intervals along the length of each dog chromo-
some to the distal end of the available genome sequence assembly, re-
sulting in a total of 2122 clones. For practical reasons clone selection 
was restricted to the smallest number of library master plates that could 
be accessed in order to result in a clone set of approximately 1 Mb. The 
BAC panel also included clones representing canine orthologues of 53 
human genes associated with a range of cancers. All BAC clone ad-
dresses and their assembly positions are provided in the supplemen-
tary online material associated with this report (located at http://www.
cvm.ncsu.edu/mbs/breen_matthew.htm- tables A and B). Locations of 
BAC clones are denoted herein according to their chromosome of ori-
gin and then their Mb position on that chromosome, according to the 
dog genome assembly (for example, CFA1; 3 Mb).
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 Cytogenetic validation of BAC clones and construction of the dog 
1 Mb array 
 BAC DNA was isolated from 2.5 ml bacterial cultures of each clone 
using a Qiagen REAL Prep 96 kit (Qiagen, Valencia, CA). Cytogenetic 
mapping was performed according to our routine multicolor FISH 
protocols (Breen et al., 2004) in groups of five consecutive, differen-
tially-labeled fluorescent probes, beginning with the most proximal 
clone on each chromosome (Thomas et al., 2007). Cytogenetic assign-
ments are reported according to the DAPI-banded dog karyotype no-
menclature of Breen et al. (1999a). In order to be included in microar-
ray construction, clones were required to generate a unique FISH hy-
bridization signal consistent with their position in the genome 
assembly. Clones that did not meet these criteria were replaced by al-
ternate selections from the assembly. If the alternate clone also failed 
to meet the required standards, that locus was excluded from all down-
stream procedures. 
 Microarray construction was performed as described previously 
using the optimized panel of BAC clones (Thomas  et al.,  2005). Array 
performance was first investigated by performing self-self and sex-mis-
match hybridization of peripheral blood DNA from clinically healthy 
donors. We then performed aCGH analysis of DNA isolated from a 
histiocytic tumor biopsy from a female Flat-Coated Retriever. Tumor 
DNA was labelled with Cyanine3-dCTP (Perkin Elmer Life Sciences, 
Boston, MA) using a BioPrime Array CGH Labelling System (Invitro-
gen, Carlsbad, CA). A reference sample representing equimolar pools 
of DNA isolated from the peripheral blood of ten clinically-healthy fe-
male Flat-Coated Retrievers was similarly labelled with Cyanine5-
dCTP (Perkin Elmer), and aCGH analysis was performed as described 
previously (Thomas  et al., 2007). A dye-swap analysis was also per-
formed, in which the test and reference samples were labelled with Cy-
anine5-dCTP and Cyanine3-dCTP respectively. Regions of genomic 
imbalance were identified using the aCGH-smooth algorithm (Jong et 
al.,  2004), with threshold limits for gain and loss set at log 2 values 
equivalent to 1.15: 1 (gain) and 0.85: 1 (loss) of tumor vs. reference ratios 
respectively.
 Evaluation of genomic imbalances by single-locus probe FISH 
analysis of tumor cells 
 Chromosome preparations were generated from a fresh biopsy spec-
imen from the histiocytic malignancy by direct harvest of tumor cells 
using conventional techniques of colcemid arrest, hypotonic treatment 
and methanol:glacial acetic acid fixation. For consistency, these cells 
were isolated from the same biopsy specimen from which the tumor 
DNA was isolated for aCGH analysis. FISH analyses of chromosome 
and interphase preparations from the tumor sample were carried out 
using single locus BAC probes (SLPs) representing selected clones from 
the 1 Mb panel, chosen from regions showing a range of normal and 
aberrant copy number ratios in aCGH. The same probes were also ap-
plied to normal dog chromosome preparations and images were ac-
quired from a minimum of 30 representative cells in each instance. The 
copy number status of each probe was scored by two independent in-
vestigators with no prior knowledge of the corresponding aCGH data. 
 Results 
 Cytogenetic analysis of the 1 Mb dog BAC panel 
 Initial (phase I) FISH analysis of our original selected 
panel of 2122 BAC clones resulted in successful placement 
of 1941 clones (91.5%) to the expected, unique chromosome 
location in full concordance with their position in the dog 
genome assembly, satisfying our criteria for use as down-
stream cytogenetic markers. Results of FISH analysis are 
summarized in  Table 1 , and  Fig. 1 demonstrates our FISH 
analysis approach, using combinations of BAC clones posi-
tioned at intervals of 10 Mb and 1 Mb on dog chromosome 
10 ( Canis familiaris , CFA). Of the 181 clones that were re-
jected since they did not meet the necessary standard, 108 
(60%) mapped to the expected chromosome location but 
showed hybridization signals at additional genomic sites 
that would confound downstream analysis. These included 
106 clones that showed one or more secondary signals that 
had no obvious association with the observed primary sig-
nal. Two further clones mapped to the centromeres of all 
chromosomes. 
 The remaining 73 (40%) clones failed to hybridize to the 
expected location. These included three clones that failed to 
revive in culture, most likely due to a fault during library 
replication, or loss of the BAC vector resulting in loss of an-
tibiotic resistance. Forty clones did not demonstrate any de-
tectable hybridization signal after multiple attempts on 
metaphase chromosome preparations from a minimum of 
two unrelated dogs. A total of 27 clones mapped to a loca-
tion inconsistent with their position in the genome assem-
bly. Nineteen of these anomalies were resolved by selecting 
alternate clones from the assembly that share contiguous 
sequence with the original BAC, and thus were unlikely to 
reflect major inconsistencies between the cytogenetic map 
Table 1. FISH analysis results
Phase I Phase II
# BACs % # BACs %
Unique location consistent with assembly 1941 91.5% 2097 98.8%
Unique location on expected chromosome but position not consistent with assembly 3 0.1% 1 0.0%
Location consistent with assembly but with additional weak secondary signal 43 2.0% 3 0.1%
Location consistent with assembly but with additional strong secondary signal 49 2.3% 3 0.1%
Location consistent with assembly but with multiple secondary signals 14 0.7% 3 0.1%
Mapped to multiple centromeres 2 0.1% 0 0.0%
Location not consistent with assembly 27 1.3% 8 0.4%
No visible FISH signal after multiple attempts on unrelated dogs 40 1.9% 7 0.3%
Selected clone repeatedly failed in culture 3 0.1% 0 0.0%
Total 2122 100.0% 2122 100.0%
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and the genome assembly. Finally, three clones (182G07, 
307O16 and 376D10) mapped to the expected chromosome 
but at a location inconsistent with the genome assembly, and 
were further investigated. For clones 182G07 and 307O16 
(from CFA1 and 6 respectively), the anomaly was resolved 
by selecting alternate clones from the genome assembly, 
which mapped to the expected location (see  Fig. 2 for de-
tails). The observed correlation between genome sequence 
and FISH data for these alternate clones, positioned 0.3 Mb 
and 0.1 Mb respectively from the original selections, implies 
that the phase I findings represent minor discrepancies in 
the placement of individual clone sequences within the ge-
nome assembly for CFA1 and CFA6 rather than extensive 
discordance between the assembly and the cytogenetic map. 
A third clone, 376D10, originally placed at CFA2; 4.3 Mb 
according to BLAST of BAC end sequences, mapped sig-
nificantly more distally than expected, and through co-hy-
bridization with clones from this region, was resolved to 
approximately CFA2; 87 Mb. This finding was subsequent-
ly attributed to misplacement in the assembly of one end of 
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 Fig. 1. FISH analysis of clones from CFA10. ( A ) The chromosome 
location of five differentially labeled clones from the previously report-
ed 10 Mb resolution dog BAC set (Thomas et al., 2007), starting with 
the most centromeric clone. The text color indicates the fluorochrome 
with which each clone was labeled for FISH analysis, and the Mb posi-
tion on CFA10 is shown after the corresponding BAC address.  To the 
left is the CFA10 ideogram, and to the right, three examples of these 
five probes hybridized to CFA10 at increasingly later stages of meta-
phase. Accurate assignment of clones at 10 Mb resolution is clearly pos-
sible in early metaphase, and probe order is easily ascertained. ( B ) Five 
probes at intervals of approximately 1 Mb, starting from the second 
clone in the previous 10 Mb set (326H08). In metaphase ( Bi ) these five 
probes at 1 Mb intervals can be accurately assigned to a chromosome 
band, but their relative order cannot be readily resolved due to exten-
sive chromosome contraction. Accurate ordering is thus reliant on in-
terphase mapping ( Bii ). 
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 Fig. 2. Use of FISH analysis to resolve 
mapping anomalies. Clone 182G07 (CFA1; 
97.5 Mb) mapped by FISH analysis to a site 
significantly more proximal to that suggested 
by the genome assembly ( A ). Co-hybridiza-
tion of this BAC with two clones from this 
more proximal region of CFA1 resolved the 
location of 182G07 to approximately CFA1; 30 
Mb ( B , left image), whilst the gap left by this 
clone was successfully filled by clone 160A04 
(CFA1; 97.2 Mb), selected from the assembly 
( B , right image). Using the same strategy, the 
location of clone 307O16 (CFA6; 61.9 Mb) was 
revised to a more proximal location (CFA6; 45 
Mb, data not shown) and the consequent gap 
was filled successfully by clone 502O13 (CFA6; 
62.0 Mb).  
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of the genome assembly. The five most proximal clones selected for 
analysis in phase I are shown in  A against the ideogram of CFA2, span-
ning a 5.2 Mb region of the genome assembly. ( B ) Left, the composite 
results of FISH analysis of these clones on both CFA2 homologues from 
one cell and right, the five separate planes of fluorescent signal corre-
sponding to each differentially labeled clone are shown individually for 
one of these homologues. Two clones (125F22 and 186C02) showed 
unique signal in the expected chromosome location. Clones 122K12 
and 191O10 also mapped where expected, but showed additional hy-
bridization sites further down the chromosome, which were of equal 
strength to the primary signal. These pairs of probe signals (arrowed) 
suggested the presence of tandem repeat sequences in this region of 
CFA2, which was supported by the identification of a similar pattern 
of results for the next distal marker from this region (199D17, CFA2; 
8.9 Mb, data not shown). Clones distal to this marker mapped to the 
expected unique location, thus the region of repetitive sequence ap-
pears to extend to approximately 9 Mb from the start of the CFA2 as-
sembly. Note that clone 376D10 (CFA2; 4.3 Mb according to the assem-
bly) mapped significantly more distally than expected, close to the 
CFA2 telomere. Through co-hybridization of 376D10 with clones from 
this region (following the strategy outlined in  Fig. 2 ), the cytogenetic 
location of this BAC was resolved to approximately CFA2; 87 Mb. This 
finding was subsequently attributed to misplacement of one end of the 
BAC clone sequence at CFA2; 4.3 Mb, most likely due to the presence 
of repetitive sequence, whilst the other end was correctly positioned at 
CFA2; 86.7 Mb. 
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 X ALL
0.5
1
1.5
2
2.5
3
3.5
4
4.5
Chromosome
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1 Mb clone set on each dog chromosome. The top and bottom of each 
vertical bar indicate the maximum and minimum interval respective-
ly (in Mb) in the optimized clone panel for each chromosome. The 
horizontal line bisecting each bar shows the mean interval size on that 
chromosome. The final bar summarizes interval data for the whole 
genome, demonstrating the mean genome-wide interval of 1.12 Mb. 
Note the large maximum interval encountered on CFA2, which is a 
consequence of the inability to identify BAC clones with unique FISH 
signals due to the presence of highly repetitive DNA sequence near the 
centromere. The large maximum interval for CFAX is due to under-
representation of the CFAX centromere in the dog genome sequence, 
which is also attributed to extensive tracts of repetitive sequence in this 
region. 
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the BAC clone sequence at CFA2; 4.3 Mb, most likely due to 
the presence of repetitive sequence, whilst the other end was 
correctly positioned at CFA2; 86.7 Mb. This region of CFA2, 
extending from 4 Mb to 11 Mb from the centromere, showed 
a unique profile of FISH results that reflect the existence of 
an extensive region of tandemly repeated DNA sequences, 
an example of which is given in  Fig. 3 . Details of clones with 
anomalous FISH data are provided in the supplementary 
online material associated with this report (http://www.
cvm.ncsu.edu/mbs/breen_matthew.htm- table C).
 After completion of phase II, following investigation of 
anomalous data and selection of alternates to replace clones 
rejected in the first phase of the study, the total number of 
clones that mapped to a unique chromosomal location in 
concordance with their position in the dog genome assem-
bly was increased to 2097 (98.8%). This optimized clone set 
provides a mean resolution of 1.12 Mb throughout the fe-
male dog genome (median 1.10 Mb, range 0.28–3.28 Mb), 
with 94.4% of intervals being  ^  1.5 Mb in size.  Figure 4 
shows the mean, maximum and minimum intervals be-
tween clones for each chromosome, and  Fig. 5 summarizes 
the distribution of interval sizes throughout the genome. 
Detailed results of FISH analysis are provided in the supple-
mentary online material associated with this report.
 Application of the BAC panel in tumor chromosome 
analysis 
 The optimized panel of 2097 cytogenetically-validated 
BAC clones was used to generate a genome-wide microarray 
resource. Results of self-self aCGH analysis of genomic 
DNA isolated from the peripheral lymphocytes of a clini-
cally normal donor ( Fig. 6 A) were consistent with the ex-
pected 1: 1 ratio of Cyanine3 versus Cyanine5 hybridization 
throughout the genome. Subsequent aCGH analysis of a his-
tiocytic tumor isolated from a female Flat-Coated Retriever 
dog revealed a wide range of whole and partial chromosome 
copy number changes throughout the genome ( Fig. 6 B, C). 
Genomic gains were observed on CFA3, 9, 13, 20 and 37, and 
copy number losses included regions of CFA5, 9, 12, 14, 16, 
19, 21, 23, 26, and 32. aCGH analysis revealed copy number 
changes involving several known cancer genes, including 
gain of  FES (CFA3),  TSC2 (CFA6), and  MYC and  KIT 
(CFA13), and loss of  BRCA1, NF1 and  ABL1 (CFA9) and 
 PTEN (CFA26). A region of high-level amplification was ob-
served on CFA20, approximately 28–30 Mb from the cen-
tromere. This region was investigated further by CGH-di-
rected single locus probe (SLP) analysis of the tumor using 
11 BAC clones from CFA20, revealing four derivative chro-
mosome structures containing regions corresponding to 
this chromosome. Enumeration of probe signals for each 
BAC clone supported their copy number ratios as deter-
mined by aCGH analysis. These data are summarized with 
examples in  Fig. 7 .
 Discussion  
 The development of the 7.6 ! dog genome sequence as-
sembly provides exciting opportunities for increasing the 
resolution, sophistication and versatility of resources for ca-
nine and comparative genomics studies. We have used the 
assembly to select and validate a genome-wide panel of an-
notated BAC clones as a tool for genome-integrated molecu-
lar cytogenetic analysis, and as a means to investigate the 
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 Fig. 6. Whole genome aCGH profiles obtained using the 1 Mb as-
sembly-integrated dog BAC array, showing composite dye-swapped ar-
ray CGH profiles of ( A ) a self-self hybridization of differentially labeled 
male reference DNA and ( B ) a DNA sample derived from a canine his-
tiocytic tumor co-hybridized with reference DNA. Data are plotted as 
the median, block-normalized and background-subtracted log 2 ratio of 
the replicate spots for each BAC clone on the 1 Mb array. Log 2 ratios 
representing genomic gain and loss are indicated by horizontal bars 
above (green line) and below (red line) the midline (orange line) repre-
senting normal copy number. The aCGH profile in  A shows that the 
copy number status throughout the genome is reported as normal, as 
expected for a self-self hybridization. In  B this chromosome copy-num-
ber status line appears as either red or green in regions where genomic 
imbalances were apparent (red = loss, green = gain), as determined by 
the aCGH Smooth algorithm (Jong et al., 2004). The profile indicates 
whole chromosome gain for CFA3, CFA13 and CFA37, and a high level 
amplification on CFA20. Genomic losses were detected on CFA5, 
CFA9, CFA12, CFA14, CFA16, CFA19, CFA21, CFA23, CFA26 and 
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correlation between the assembly-derived position of each 
clone and its cytogenetic location, through integrated as-
signment of this framework panel of clones by both tech-
niques. In the first phase of cytogenetic analysis, 91.5% of 
the 2122 BAC clones selected fulfilled our required criteria, 
confirming the high quality of the assembled dog genome 
sequence. In the second phase of cytogenetic analysis we 
were able to increase the level of concordance to 98.8%, by 
assessing alternate clones as potential replacements for 
those rejected during phase I. The cytogenetic distribution 
of the resulting optimized clone set shows excellent full-
length coverage of each dog chromosome, with the known 
exception of the highly-repetitive centromeric regions. Tak-
ing into account the fluctuations in clone positions as the 
genome assembly has developed since our original clone se-
lection, the distribution of intervals between consecutive 
clones on each chromosome is highly consistent.  Figure 4 
shows two major exceptions, namely CFA2 and CFAX, 
which are deficient in clone density at the centromeres. We 
have shown previously (Thomas  et al., 2007) that clone 
283A18 (CFAX; 47.9 Mb) maps by FISH analysis to the cen-
tromere of CFAX. This site is proximal to a gap in the ge-
nome sequence assembly of approximately 3.04 Mb that is 
devoid of mapped BAC ends due to the density of repetitive 
DNA, consistent with its heterochromatic nature. As a con-
sequence, an interval of 3.79 Mb exists in this region of our 
CFAX BAC map. This is consistent with the mean 3.17 Mb 
gap in the map of BAC end sequences at the centromere of 
each autosome in the genome sequence assembly, where, 
unlike the submetacentric X chromosome, their telocentric 
structure does not result in interruption of the cytogenetic 
map. We did, however, identify two clones 326K03 (CFA1; 
3.1 Mb) and 330E21 (CFA37; 6.4 Mb) that mapped to the 
centromeres of all chromosomes, although with variable 
signal intensity, suggesting that they contain highly repeti-
tive sequence that is more highly represented on certain 
chromosomes as compared to others. 
 Tracts of repetitive sequences were not restricted to chro-
mosome ends. Whilst not apparent from the annotation of 
the genome assembly itself, FISH analysis of clones within 
the region extending 9 Mb from the centromere of CFA2 
showed multiple hybridization signals that were confined to 
this short length of the chromosome ( Fig. 3 ). These findings 
revealed the existence of an extensive and previously unre-
ported region of tandemly repeated DNA sequence that pre-
cluded the identification of clones with unique FISH pro-
files, resulting in an interval of 3.89 Mb near CFA2qcen in 
our genome-integrated BAC panel. This region is now being 
investigated in more detail in a separate study.
 Another well-known region of sequence homology was 
identified by this study, namely the pseudoautosomal re-
gion shared by the sex chromosomes. FISH analysis of 
clones selected at 1 Mb intervals from the CFAXp chromo-
some assembly revealed the subset of clones that co-hybrid-
ize to the homologous region of CFAYp, and through high-
er resolution FISH analysis of additional BAC clones select-
ed from the assembly, enabled the precise boundaries of this 
region to be elucidated. These data are presented elsewhere 
(Young et al., manuscript in preparation). 
 The development of a genome-integrated BAC map has 
thus generated new insights into the structure of domestic 
dog chromosomes, and provides extensive opportunities 
for detailed evaluation of genome organization both in nor-
mal individuals and also, perhaps more importantly, in ab-
errant karyotypes. This application has particular relevance 
in light of the recent explosion in interest in cancer genom-
ics, both in human and veterinary medicine, where the abil-
ity to perform translational studies based on comparative 
analyses has enormous potential for mutual advances in 
disease diagnosis, prognosis and development of novel ther-
apeutics. Recently we have shown for the first time that hu-
man and canine counterparts of the same cancer share evo-
lutionarily conserved chromosome aberrations that result 
in structural and numerical defects of the same genes (Breen 
and Modiano, 2008). These observations provide direct ev-
idence for the non-random basis of tumor-associated chro-
mosome arrangement and genomic aneuploidy, although 
the mechanisms by which they occur are not fully under-
stood. We anticipate that the resource detailed in the pres-
ent study has enormous potential to contribute towards an-
swering this and similar fundamental questions in molecu-
lar oncology. Characterization of dog tumor-associated 
chromosome aberrations is highly challenging and labor-
intensive using classical cytogenetics techniques alone, par-
ticularly in view of the similarity in size, morphology and 
banding pattern of many of the smaller dog chromosomes. 
The development of a cytogenetically-validated, genome in-
tegrated BAC panel for each dog chromosome now over-
comes these limitations. We have expanded the ability for 
comparative tumor cytogenetics studies through the vali-
dation by FISH analysis of dog BAC clones representing 53 
key cancer-associated genes, which are now being used in 
our ongoing studies of a wide range of dog tumors and their 
human counterparts. We limited our selection to CHORI-
82 clones that contain the full length of the corresponding 
gene according to the annotated dog genome browser, which 
should serve to facilitate future studies directed towards 
more localized sequence analysis of these key loci. Our own 
aims, however, are focused heavily on the identification of 
gene sequences that are associated with the onset and/or 
behavior of dog tumors, but whose role in human and/or 
veterinary studies has not previously been described. We 
demonstrate how our assembly-integrated aCGH and cyto-
genetic resources might be used towards this goal using the 
example of a case of histiocytic sarcoma in a female Flat-
Coated Retriever, which was recruited into an ongoing 
study of these tumors by our group. This case has previ-
CFA32. The amplification on CFA20 is enlarged to show more detail 
in  C , depicting the copy number ratio for all clones distributed along 
this chromosome. A subset of these clones (indicated on the CFA20 
profile in C) was subsequently used as SLPs for FISH analysis of tumor 
chromosomes. The color of the text used for each clone address corre-
sponds to the fluorochrome with which it was labeled, and the number 
shown against each clone address shows which clones were grouped 
together in FISH analysis (see Fig. 7A–E for details). 
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ously been analyzed using our 10 Mb-resolution BAC mi-
croarray (Thomas et al. ,  2007), with which we detected 
chromosome copy-number changes including gains of 
CFA3, CFA13 (including the  KIT  and  MYC proto-onco-
genes), CFA20 and CFA37, and losses including CFA16, 23 
and 26 (including the  PTEN tumor-suppressor gene). Most 
striking was a region of amplification at CFA20q12dist ] 
q13prox corresponding to BAC clone 126D04 (CFA20; 23.1 
Mb). Using aCGH-directed SLP analysis of tumor meta-
phase preparations, we previously identified four chromo-
some structures containing regions corresponding to 
CFA20, each with a different size, morphology and probe 
hybridization profile resulting from several structural and 
numerical chromosome changes (Thomas et al.,  2007). 
FISH analysis showed that the amplification corresponding 
to clone 126D04 was consistent with the presence of six cop-
ies of this region distributed across all four of these abnor-
mal chromosome structures. By reference to the dog ge-
nome assembly browser (http://genome.ucsc.edu) we iden-
tified a gene,  FOXP1 , less than 1 Mb distal to clone 126D04, 
for which genomic changes have been associated with prog-
nosis in human cancers (for example, Barrans  et al., 2004; 
Fox et al.,  2004). We are now investigating this region with 
particular interest in a wider study of dog tumors. 
 We elected to use this same case for extended analyses 
using the 1 Mb resolution microarray in order to demon-
strate the degree of additional genomic information that 
can be extracted as we continue to increase the sophistica-
tion of available resources. aCGH analysis of the histiocytic 
tumor with this higher resolution array confirmed the pres-
ence  of  previously  identified  copy   number   changes   but  
also  revealed other regions of genomic imbalance, includ-
ing several additional subchromosomal gains and losses 
( Fig. 6 B), further emphasizing the complex nature of this 
tumor karyotype.  Figure 6 C shows a detailed view of the 
aCGH profile for CFA20. It is evident from this that the peak 
of amplification corresponding to clone 126D04 (CFA20; 
23.1 Mb) identified using the 10 Mb array lies proximal to a 
region of apparently even greater amplification peaking at 
the site delineated by clones 465J12, 188L06 and 043N06 
(CFA20; 28.0–30.0 Mb), beyond which the distal half of 
CFA20 appears to be balanced. Clones distributed along 
CFA20 were assessed in SLP analysis of tumor chromo-
somes ( Fig. 7 ) and showed close correlation with aCGH 
data, indicating the presence of more than seven copies of 
regions corresponding to clones in the region of high-level 
amplification. We also carried out SLP analysis using clone 
308B21, which contains the full length of the  FOXP1 gene, 
and confirmed that over 75% of cells sampled from the his-
tiocytic tumor carry six or more copies of this region.
 Clone 465J12 (CFA20; 28 Mb) lies in the region of high-
level amplification, with a modal copy number of seven per 
cell (increasing to ten copies in a small proportion of cells), 
representing the most extreme copy number increase we 
have observed in dog cancers to date. By reference to the dog 
genome assembly browser we established that this clone 
contains the full coding sequence of gene  LRIG1 . Tumor-as-
sociated chromosomal gain of the evolutionarily conserved 
region in the short arm of human chromosome 3 (specifi-
cally HSA3p14) has previously been correlated with overex-
pression of the  LRIG1 gene (Ljuslinder et al., 2005). In turn 
the amplified status of the  LRIG1 gene has been proposed to 
confer an improved prognosis in several human cancers (for 
example, Yang et al., 2006; Lindstrom et al., 2008) by acting 
as a tumor-suppressor (Hedman et al., 2002; Shattuck et al., 
 2007). Recently this hypothesis has been revised to suggest 
that  LRIG1 copy number and expression levels may in fact 
have either positive or negative impacts on prognosis de-
pending on the specific cellular environment (Hedman and 
Henriksson, 2007). With increasing evidence for the corre-
lation between copy number imbalances and gene expres-
sion changes (for example, Hyman et al., 2002; Sweet-Cor-
dero et al., 2006; Lilljebjorn et al., 2007), our interest in this 
region of CFA20 has increased further as a result of these 
observations and we are continuing to monitor its frequen-
cy and distribution in dog tumors. 
 The expanding panel of genomics resources for the dog, 
and now the ease with which we can identify BAC clones 
representing genes of specific interest from the sequence as-
sembly,  provides  long-awaited  opportunities  to  evaluate 
the significance of genomic aneuploidy in canine cancers. 
Through application of genome-integrated cytogenetic re-
sources in both species it is likely that we will continue to 
identify evolutionarily related chromosomal defects in hu-
man and canine counterparts of the same cancer. Our ra-
tionale for developing this canine genomics resource is, 
however, to permit the detection of novel genetic features in 
the dog whose role has not yet been evaluated in the human 
field. The use of the dog genome as a powerful tool for gene 
discovery has been demonstrated in several prior studies, 
 Fig. 7. Targeted FISH analysis of CFA20 in the dog histiocytic sar-
coma case, using clones from the 1 Mb array. Based on results of aCGH 
analysis, a panel of 11 BAC clones was selected for detailed character-
ization of copy number status along CFA20. Probes were combined 
into three groups of five differentially-labeled probes for FISH analysis 
(with four probes represented twice). All clones were hybridized onto 
normal metaphase chromosome preparations from a clinically healthy 
donor, to confirm the expected probe location relative to the CFA20 
ideogram ( Fig. 5 A). The resulting images of probe signals on normal 
banded chromosomes are shown in  B – D , and these data are summa-
rized schematically in  E . The text color corresponds to the fluoro-
chrome with which each BAC probe was labeled, and the Mb position 
of each clone on CFA20 is also shown. ( F–K ) Results of FISH analysis 
using the same three groups of BAC clones on the histiocytic sarcoma 
case. These data demonstrate four distinct chromosome structures 
harboring regions corresponding to CFA20, each with a different mor-
phology and probe hybridization profile. These four structures com-
prised two metacentric chromosomes, one sub-metacentric chromo-
some and one small acrocentric chromosome whose SLP profile was 
consistent with that of a grossly normal CFA20. The modal copy num-
ber for each probe in all cells analyzed is shown below the correspond-
ing chromosome structure. Note that assessment of copy number sta-
tus is challenging for probes showing high level amplifications, since 
apparent tandem duplications often result in large probe signals that 
cannot be resolved fully even in interphase preparations. Modal copy 
numbers are therefore based on analysis of both metaphase and inter-
phase chromosomes from  1 30 cells in each instance. 
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most notably detection of the  HCRTR2 gene disruption re-
sponsible for canine narcolepsy (Lin et al., 1999), and the 
mutation associated with canine hereditary multifocal re-
nal cystadenocarcinoma and nodular dermatofibrosis (Lin-
gaas et al., 2003), both of which share phenotypic counter-
parts in human medicine. These studies have set the scene 
for similar achievements in the detection of novel tumor-as-
sociated genes. 
 We have shown in the present study that the 1 Mb reso-
lution genome-integrated cytogenetic BAC map enables in-
vestigation of genome structure, both in normal and malig-
nant cells. The correlation of fragile sites in the human ge-
nome with chromosome instability and clinical disorders, 
including cancer, has long been recognized (see Sutherland 
and Baker, 2000 for a review). More recently, several sites of 
non-random chromosome disruption in human tumors 
have been shown to coincide with known synteny break-
points in the genomes of a diverse set of species (for exam-
ple, Darai et al., 2005). This suggests that the regional struc-
tural instability of specific chromosome sequences contrib-
utes to chromosome evolution in both the long- (between 
species) and short-term (during tumor development within 
species). The gross structural relationship between the dog 
and human genomes has already been established (Breen et 
al., 1999b, 2004; Yang et al., 1999), revealing the sites of 
chromosome breakage and fusion that have occurred dur-
ing divergent evolution from their common ancestral karyo-
type. Through cytogenetic assignment of domestic dog 
BAC clones to the chromosomes of other canids, as well as 
other mammalian species, interruptions in conserved syn-
teny can now be refined at higher resolution. With the abil-
ity to identify the precise DNA sequence at these chromo-
some sites in multiple species we now have an excellent op-
portunity to elucidate the relationship between evolutionary 
breakpoints and those associated with tumorigenesis. 
 The global value of this 1 Mb array extends well beyond 
its two-fold increase in resolution over our previously de-
scribed resource (Thomas et al., 2005). Due to the selection 
of all arrayed targets at uniform intervals directly from 
within the dog genome assembly, the array offers complete 
correlation between observed cytogenetic aberrations and 
the underlying gene sequence without the need to generate 
DNA sequence information from arrayed targets. This in 
turn facilitates investigation of the biological consequence 
of gross genomic alterations in dog cancers, and indeed in 
any phenotype resulting from chromosome abnormalities, 
whether structural or numerical, that can be observed using 
molecular cytogenetic techniques. To our knowledge the 
development of this CGH microarray now places the dog in 
a position equivalent to only the traditional rodent model, 
the laboratory mouse, in terms of the resolution of such re-
agents (Chung et al., 2004) for non-human species. It now 
becomes possible to characterize precise gene content at the 
site of chromosome breakpoints in cancer, and to generate 
higher-resolution microarrays for subchromosomal regions 
of specific interest. The technique of array-painting, using 
microdissected/flow-sorted chromosomes to probe genom-
ic microarrays, will now enable complete characterization 
of the gene content of complex tumor-associated derivative 
structures in the dog, which to date has been possible only 
in the human field (Fiegler et al., 2003; Backx et al., 2007; 
Gribble et al., 2007). The ultimate goal will be the construc-
tion of a tiling-path array for the entire dog genome, com-
prising overlapping genomic clones with complete coverage 
of each chromosome, which to date is available only for hu-
man studies (Ishkanian et al., 2004). 
 Supplementary online materials 
 The following additional data will be provided at the correspond-
ing author’s website: http://www.cvm.ncsu.edu/mbs/breen_matthew.
htm
 SOM Table A: Comprehensive list of mapping data for all clones 
comprising the 1 Mb resolution genome-integrated and cytogeneti-
cally validated BAC panel.
 SOM Table B: Mapping data for BAC clones containing specific 
genes targeted for inclusion in the BAC panel.
 SOM Table C: List of BAC clones with anomalous FISH mapping 
data. 
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